Legal Representation
Attorney
Mark J. Liss
USPTO Deadlines
Next Deadline
1471 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20231226)
Due Date
December 26, 2029
Grace Period Ends
June 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 23, 2024 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Mar 27, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Mar 27, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Mar 26, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jan 2, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Dec 26, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 26, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 13, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 13, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Oct 10, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Oct 10, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 10, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 20, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Sep 20, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Sep 20, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 1, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 8, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 8, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 8, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 29, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 3, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 3, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jan 7, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jan 6, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 12, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 8, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 7, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical agents affecting sensory organs; muscle relaxants; preparations for the treatment of muscle fatigue;pharmaceutical agents affecting peripheral nervous system; vaccines; pharmaceuticals containing botulinum toxin for medical use for use in treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, neuropathy pain and pelvic pain; bacteria poisons;pharmacological preparations for skin care; chemico-pharmaceutical preparations for skin care, skin wounds, prevention of migraines; pharmaceutical agents for epidermis; biological preparations for medical or veterinary purposes being bacterial and bacteriological preparations; medicated lotions for skin, sunburn, face, body; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; medical infusions for treating migraine headaches, excessive sweating, urinary incontinence; injectable dermal fillers; implantable medicines being medicinal infusions, injectable gels, injectable pharmaceuticals for use in the treatment of anaphylactic reactions, migraine headaches, urinary incontinence, neurological disorders and muscle dystonia; pharmaceutical preparations acting on the central nervous system; pain relief medication; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders
Additional Information
Pseudo Mark
NEW LUX
Classification
International Classes
005